Claire Forde
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 04, 2026
A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosis.
Journal: Neuro-oncology advances
Published: December 11, 2025
Validation of the pathology-adjusted Manchester scoring system in over 10 000 assessments of cases with breast and/or ovarian cancer.
Journal: Journal of medical genetics
Published: April 19, 2025
UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants.
Journal: Journal of medical genetics
Published: January 14, 2025
Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma.
Journal: Clinical genetics
Published: December 23, 2024
Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?
Journal: Journal of medical genetics
Published: June 14, 2024
NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.
NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study.
Journal: Journal of medical genetics
Published: April 23, 2024
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: April 13, 2024
Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC).
Journal: ESMO real world data and digital oncology
Published: March 11, 2024
Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2.
Journal: Journal of medical genetics
Published: December 16, 2023
Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 30, 2023
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
Journal: Familial cancer
Published: October 18, 2023
Last Updated: 09/26/2026